Alex­ion’s new CEO is bring­ing an old col­league in to run R&D, can new deals be far be­hind?

Af­ter an­nounc­ing a clean sweep of the ex­ec­u­tive suite a few days ago, Alex­ion’s new CEO Lud­wig Hantson is bring­ing in a very fa­mil­iar face to take over as head of R&D.

Hantson chose John Orloff, his R&D chief at the short-lived Bax­al­ta, to take over the helm at Alex­ion’s re­search group, re­plac­ing Mar­tin Mack­ay. The move like­ly sig­nals some loom­ing pipeline changes at the com­pa­ny, which sells Soliris, one of the world’s most ex­pen­sive ther­a­peu­tics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.